Skip to content

Immediate Versus Delayed FET Following a Stimulated IVF Cycle

A Randomized Trial Comparing the Effect of Immediate Versus Delayed Frozen-thawed Embryo Transfer Following a Stimulated IVF Cycle

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03201783
Enrollment
724
Registered
2017-06-28
Start date
2017-08-09
Completion date
2019-12-31
Last updated
2020-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Embryo Transfer, Fertilization in Vitro

Keywords

frozen-thawed embryo transfer, time interval

Brief summary

Information regarding the optimal timing for frozen-thawed embryo transfer (FET) following a stimulated in vitro fertilization (IVF) is lacking. One option is to perform FET in the first cycle following the stimulated IVF cycle, i.e. immediate transfer. Another option is to postpone FET for at least one menstrual cycle, i.e. delayed transfer. This randomized study aims to compare the ongoing pregnancy rate of immediate versus delayed FET following a stimulated IVF cycle.

Interventions

OTHERimmediate frozen-thawed embryo transfer

Frozen-thawed embryo transfer will be performed in the first cycle following the stimulated IVF cycle

OTHERdelayed frozen-thawed embryo transfer

Frozen-thawed embryo transfer will be performed at least in the second cycle following the stimulated IVF cycle

Sponsors

The University of Hong Kong
CollaboratorOTHER
ShangHai Ji Ai Genetics & IVF Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Masking description

No masking because of the nature of the intervention

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 43 Years
Healthy volunteers
No

Inclusion criteria

* Women aged ≤43 years at the time of IVF/ICSI treatment Undergoing IVF with a standard stimulation At least one frozen embryo or blastocyst The first FET cycle following ovarian stimulation in IVF/ICSI

Exclusion criteria

* Use of mild stimulation or natural cycle for IVF/ICSI treatment Severe ovarian hyperstimulation syndrome during IVF/ICSI treatment Preimplantation genetic diagnosis treatment Use of donor oocytes Presence of hydrosalpinx which is not surgically treated or endometrial polyp on scanning during ovarian stimulation

Design outcomes

Primary

MeasureTime frameDescription
ongoing pregnancyviable pregnancy beyond gestation 12 weeksviable pregnancy beyond gestation 12 weeks

Secondary

MeasureTime frameDescription
Positive hCG levelA blood pregnancy test is performed 14 days after the FETthe result of serum β-hCG ≥10 mIU/mL.
clinical pregnancypresence of intrauterine gestational sac on ultrasound at 6 weeks of pregnancypresence of intrauterine gestational sac on ultrasound
biochemical pregnancy:positive blood pregnancy test not followed by clinical pregnancy during 12 weeks gestationpositive blood pregnancy test not followed by clinical pregnancy
implantation ratenumber of gestational sacs per embryo transferred during 4 weeks of pregnancynumber of gestational sacs per embryo transferred
multiple pregnancymultiple pregnancy beyond gestation 12 weeksmore than one intrauterine sacs on scanning
miscarriagethe loss of a pregnancy before 22 weeks gestationthe loss of a pregnancy before 22 weeks gestation
live birth ratea live birth after 22 weeks gestationthe rate of live births per cycle
birth weighta live birth after 22 weeks gestationbirth weight of the baby delivered
ectopic pregnancyectopic pregnancy during 12 weeks gestationpregnancy outside the uterine cavity

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026